← Leaderboards
Lali K Medina-Kauwe
Cedars-Sinai Medical Center
$10,679,116
Attributed
$10,679,116
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $789.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,679,116 · 6
By mechanism
R01$10,329,316 · 5
R21$349,800 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Serum”
- Joseph B. Margolick · Johns Hopkins University$72,041,404
- Monica M Bertagnolli · Strang Cancer Prevention Center$59,344,476
- Leonardo Trasande · New York University School Of Medicine$53,176,255
- Bradley F Boeve · Mayo Clinic Rochester$50,650,130
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$50,055,104
- Laurence H Baker · University Of Michigan At Ann Arbor$48,684,161
Research focus
SerumTumorReceptorProteinsCellsPenetrationNeoplastic CellTreatment EfficacyEpidermal Growth Factor ReceptorMembraneToxic EffectIn VitroErbb2 GeneMediatingLigandsSignal TransductionVariantMalignant Breast NeoplasmTraffickingBreast Cancer TreatmentMammary NeoplasmsIn VivoParticleCapsid
Grant awards (34)
Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids$382,013
R01 · FY2025 · CA · contact PI
Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases$382,013
R01 · FY2025 · CA · contact PI
Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids$362,913
R01 · FY2024 · CA · contact PI
Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids$374,372
R01 · FY2023 · CA · contact PI
Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases$374,372
R01 · FY2023 · CA · contact PI
Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases$382,013
R01 · FY2022 · CA · contact PI
Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids$372,817
R01 · FY2022 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$415,625
R01 · FY2021 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$390,343
R01 · FY2020 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$261,782
R01 · FY2020 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$101,059
R01 · FY2019 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$12,812
R01 · FY2019 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$415,625
R01 · FY2018 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$374,063
R01 · FY2018 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$415,625
R01 · FY2017 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$374,063
R01 · FY2017 · CA · contact PI
Corrole nanobiologics for targeting resistant and metastatic tumors$407,075
R01 · FY2016 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$374,063
R01 · FY2016 · CA · contact PI
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors$374,063
R01 · FY2015 · CA · contact PI
Tumor Targeted Corroles for Detection and Intervention$322,141
R01 · FY2014 · CA · contact PI
Tumor Targeted Corroles for Detection and Intervention$312,178
R01 · FY2013 · CA · contact PI
Tumor Targeted Corroles for Detection and Intervention$332,104
R01 · FY2012 · CA · contact PI
Protein-DNA Drug Carriers for Tumor Targeting$288,593
R01 · FY2012 · CA · contact PI
Tumor Targeted Corroles for Detection and Intervention$332,104
R01 · FY2011 · CA · contact PI
Protein-DNA Drug Carriers for Tumor Targeting$294,365
R01 · FY2011 · CA · contact PI
Tumor Targeted Corroles for Detection and Intervention$342,375
R01 · FY2010 · CA · contact PI
Protein-DNA Drug Carriers for Tumor Targeting$303,469
R01 · FY2010 · CA · contact PI
Protein-DNA Drug Carriers for Tumor Targeting$272,345
R01 · FY2009 · CA · contact PI
A NOVEL TARGETED THERAPEUTIC USING VIRAL CAPSID PROTEIN$190,800
R21 · FY2008 · CA · contact PI
A NOVEL TARGETED THERAPEUTIC USING VIRAL CAPSID PROTEIN$159,000
R21 · FY2007 · CA · contact PI
Heregulin-Targeted Protein Uptake for Breast Cancer$234,027
R01 · FY2006 · CA · contact PI
Heregulin-Targeted Protein Uptake for Breast Cancer$239,659
R01 · FY2005 · CA
Heregulin-Targeted Protein Uptake for Breast Cancer$239,659
R01 · FY2004 · CA
Heregulin-Targeted Protein Uptake for Breast Cancer$269,586
R01 · FY2003 · CA